Document is current
Any future updates will be listed below
-
Authors
Barreto, Patrícia http://orcid.org/0000-0002-3375-551X
Farinha, Cláudia
Coimbra, Rita
Cachulo, Maria Luz
Melo, Joana Barbosa
Lechanteur, Yara
Hoyng, Carel B.
Cunha-Vaz, José
Silva, Rufino
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02748824 at ClinicalTrials.govnct01715870 at ClinicalTrials.govDocuments that mention this clinical trial
Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration. Coimbra Eye Study Report 8
https://doi.org/10.1186/s40662-023-00355-0
Documents that mention this clinical trial
Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration. Coimbra Eye Study Report 8
https://doi.org/10.1186/s40662-023-00355-0
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited
- License Information
-
More Information
Article History
Received: 11 January 2023
Accepted: 25 July 2023
First Online: 14 August 2023
Declarations
:
: Patients signed the informed consent after explanation of study procedures and possible consequences. The studies obtained the Association for Innovation and Biomedical Research on Light and Image (AIBILI)’s Ethics Committee approval. Five-year Incidence of Age-related Macular Degeneration in the Central Region of Portugal (AMD IncidencePT); NCT02748824, Number of the study in the Ethics Committee: CE219; Lifestyle and Food Habits Questionnaire in the Portuguese Population Aged 55 or More; NCT01715870, Number of the study in the Ethics Committee: CE 184.
: The informed consent form signed by participants referred data would be used for publication.
: PB, RC, MLC declare they have no competing interests. CF is a consultant for Bayer and Novartis; YL is a recipient for Novartis and a consultant for Bayer; CBH is a consultant for Bayer, Novartis, Horus Pharma, Abbvie and Horama. He is also a co-founder of Astherna; JCV is a consultant for Carl Zeiss Meditec, Ciana Therapeutics, Alimera Sciences, Boehringer Ingelheim, Allergan, Bayer, Gene Signal, Novartis, Pfizer, Oxular, Roche, Sanofi, Vifor Pharma and Adverum Biotechnologies; RS is a consultant for Alimera, Abbvie, Novartis, Bayer, Roche, Thea and Novo Nordisk.
